Best Biopharma Outsourcing Companies in Switzerland
The 118 best Biopharma Outsourcing companies in Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Vicarius Pharma.
Switzerland's Biopharma Outsourcing companies, ranked by disclosed equity funding and recent momentum, represent a quieter but serious corner of a market that doesn't stay quiet for long. The global biopharma outsourcing sector sits at $28.7B in 2024 and is forecast to reach $112.3B by 2032, a 5.8% CAGR driven by rising drug development costs and intensifying regulatory compliance pressure. The 118 companies we track in Switzerland have disclosed $101M in total funding combined, no unicorns yet, but the top filers show real concentration: Medimaps Group leads at $20M, Axmed follows at $18M, and Develco Pharma has filed $11M.
So what does that tell you about this cluster? It's still early-stage, spread across a mix of clinical services, biologics support, and drug development infrastructure, with investors like Venture Kick and BioArk doing most of the heavy lifting. I'd note that the absence of unicorns isn't a weakness signal here, it's a structural feature of Swiss biopharma outsourcing, where capital tends to be disciplined and deployment is slower. Coverage of clinical trial outsourcing themes is rising, and the sector's median app install growth of 13% year-over-year across outsourcing categories suggests demand is pulling forward faster than headline funding rounds imply.
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Switzerland
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Vicarius Pharma Provider of market access & HEOR consulting services | $22M | 106 mo ago | 3 | Hans Hasler CEO & President | — | — | — | — |
| 2 | Medimaps Group Developer of AI-powered bone health assessment software | $20M | 54 mo ago | — | Didier Hans CEO & President | WordPressMySQLPHP+15 | — | 33 patents AI-driven texture analysis of medical imaging for tissue and bone diagnostics | — |
| 3 | Axmed Platform connecting healthcare providers with prequalified medicine manufacturers in low- and middle-income… | $18M | 4 mo ago | — | Sofía Radley-Searle Co-Founder & COO | WordPressApple iCloud MailMicrosoft 365+20 | — | — | 1 partnership · 1 award |
| 4 | Develco Pharma Development of APIs and controlled release solid dosage forms | $11M | 20 mo ago | 130 | — | WordPressPleskMySQL+20 | — | 68 patents Controlled-release oral dosage forms and depression therapeutics using hydroxynorketamine. | 1 award |
| 5 | Alpex Pharma CRO company offers services for pharmaceutical companies | $9M | 226 mo ago | 50 | Shahbaz Ardalan CEO & MD | WordPressMySQLPHP+15 | — | 113 patents Oral solid dosage formulations: extended‑release, orodispersible, and granular drug delivery systems. | — |
| 6 | Acthera Therapeutics Provider of research, development, and manufacturing services for small molecule drugs | $6M | 59 mo ago | 10 | Andreas Zumbuhl Co-Founder | — | — | — | — |
| 7 | CARBOGEN AMCIS CDMO specializing in highly potent APIs | $4M | 57 mo ago | 1,001 | Pascal Villemagne Group CEO | JoomlaApple iCloud MailPHP+17 | 3 signals ▲50% Announcements · Leadership · Funding | 12 patents Synthesis of psilocybin derivatives and hydroxy‑vitamin D analogs for therapeutic use | — |
| 8 | Rivia Develops tool for drug clinical trials | $3M | 24 mo ago | — | — | — | — | — | 1 award |
| 9 | BIONTER CRO providing bio analytical services | $3M | 49 mo ago | 5 | Tobias Werk CEO | — | — | 13 patents Disposable diagnostic containers and liquid sample testing devices for point‑of‑care analysis | — |
| 10 | FluoSphera CRO focused on providing drug development services for biopharma sector | $2M | 5 mo ago | 3 | Aurélien Roux Co-Founder | — | — | — | 1 partnership |
| 11 | SpiroChem Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and… | $612K | 74 mo ago | 95 | Erick Carreira Member of the Board of Directors and Co-Founder | October CMSPHPGoogle Maps+24 | — | 4 patents Synthesis of substituted bicyclo[1.1.1]pentane scaffolds for drug discovery | — |
| 12 | Epithelix Provider of 3D tissue and testing services for in-vitro drug testing for respiratory cells | $611K | 77 mo ago | — | Samuel Constant COO & Co-Founder | PHPGoogle MapsVimeo+11 | — | — | — |
| 13 | Doppl Provider of clinical research, drugs development, and compounding services | $576K | 28 mo ago | — | Nathalie Brandenberg Founder & CEO | — | — | — | — |
| 14 | PKNM Solutions Provider of research, development, and consulting services in health and life sciences | $560K | 77 mo ago | — | Petros Malitas CEO & Managing Director | — | — | — | — |
| 15 | Bioscibex Biotechnology company developing single-use bioreactors for bioproduction | $188K | 8 mo ago | — | Francois Carruzzo Co-Founder & CTO | — | — | — | — |
| 16 | Calico Biosystems Provider of research services and drugs for cancer patients | $167K | 23 mo ago | — | Riccardo Turrini Co-Founder | — | — | — | 2 awards |
| 17 | Nemosia Provider of preclinical services to neurological disorders | $165K | 57 mo ago | 5 | — | — | — | — | — |
| 18 | Swiss Clinical Trial Organisation Provider of clinical trial supply services | $148K | 52 mo ago | — | Victoria Sarraf Managing Director | WordPressApple iCloud MailMicrosoft 365+19 | — | — | — |
Top 12 Biopharma Outsourcing companies in Switzerland
#1
Seed · Basel, Basel City · founded 2023$18Mraised▾
Platform connecting healthcare providers with prequalified medicine manufacturers in low- and middle-income countries. It operates a marketplace that facilitates the sourcing and supply of medicines. The company also provides advisory services to pharmaceutical companies, assisting them in expanding their presence in low- and middle-income countries by developing access strategies. The aim is to improve patient access to quality and affordable medicines.
- Feb 2026Grant (prize money)$6M
- May 2025Grant (prize money)$5M
- May 2024Seed$2M
- Grant (prize money)$5M
#2
Seed · Geneva, Geneva · founded 2020 · 3 employees$2Mraised▾
CRO focused on providing drug development services for biopharma sector
- Jan 2026Seed$1.4M
- Mar 2023Seed$1M
- Dec 2022Seed$1M
- Aug 2021Grant (prize money)$54.6K
#3
Series A · Pratteln, Basel Landschaft · founded 2006 · 130 employees$11Mraised▾
Develco Pharma is focussed on providing contract manufacturing services for API and controlled release solid dosage forms. Its services include sourcing and development of APIs, project management from evaluation through all stages of project execution, analytical services to support the pharmaceutical development process, clinical development and advise in the design and monitoring of clinical and registration. The company's product portfolio has 6 products which have been approved in Europe and 1 in the US.
#4
Seed · Monthey, Valais · founded 2024$188.2Kraised▾
Biotechnology company developing single-use bioreactors for bioproduction. The company develops all-in-one single-use bioreactors for cell culture and biologic drug production. The company's technology enables integrated cell culture system, allowing bioproduction.
- Sep 2025Seed$188.2K
#5
Seed · Zurich, Zurich · founded 2022$3.2Mraised▾
Developer of medical data platform designed to monitor biotech clinical trials. The company's platform develops an oversight over clinical trials by automated workflows and manages clinical trials in real-time by automatically combining data sources, thereby assisting biotech companies to track and interpret data in a better way that saves time.
#6
Series B · Geneva, Geneva · founded 2006$20Mraised▾
Developer of AI-powered bone health assessment software. This software comprehensively assesses bone microarchitecture and predicts fracture risk using existing imaging data. The technology integrates into clinical workflows, providing clinicians with tools to improve fracture risk detection, treatment planning, and monitoring. It offers insights beyond bone density, considering bone microarchitecture for a more complete patient assessment. The software is designed for ease of use and efficiency within clinical settings.
- Dec 2021Series B$20M
#7
Deadpooled · Kussnacht, Schwyz · founded 2016 · 3 employees$21.8Mraised▾
Provider of market access & HEOR consulting services
- Aug 2017Series A$21.8M
#8
Seed · Lausanne, Vaud · founded 2023$167.2Kraised▾
Calico Biosystems is a testing platform for cancer therapeutics, providing precision oncology services for pharmaceutical and biotech companies. They merge innovative experimental and digital approaches to assess the potency of therapeutics on patient tumors, offering a solution to the poor efficacy of anti-cancer drugs in patients.
- Jun 2024Seed$167.2K
#9
Seed · Basel, Basel Stadt · founded 2019 · 10 employees$5.8Mraised▾
Developer of hard-shelled liposomes designed to optimize the therapeutic effect while minimizing the side effects. The company's proprietary liposomes (hard-shelled liposomes, HSL) allow for the highly targeted release of therapeutic molecules at the exact site of the pathological process of the disease, enabling clinicians to increase the efficacy and decrease the side effects, as a way to widen the therapeutic window of drugs.
- Jul 2021Seed$5.8M
#10
Seed · Basel, Basel Stadt · founded 2020 · 5 employees$3.1Mraised▾
CRO providing bio analytical services
- Apr 2022Seed$3M
- Aug 2021Seed$43.6K
- May 2021Seed$11.1K
#11
Acquired · Bubendorf, Basel Landschaft · founded 1990 · 1001 employees$4.4Mraised▾
CARBOGEN AMCIS is a CDMO that supports the development process from drug discovery to commercialization. Its capabilities range from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) and drug products for preclinical studies, clinical trials and commercial use. They specialize in high potent API development and manufacturing and also offer analytical, chromatography and formulation services (mainly for parenteral drugs). The company was acquired by Dishman Pharma in 2006 and currently operates as one of its subsidiaries.
#12
Funding Raised · Lausanne, Vaud · founded 2022$575.8Kraised▾
Doppl is a Swiss biotech company that has created a global, crowd-sourced database of biological samples to power critical research and drug development. Doppler, on the other hand, is a cloud-based platform that redefines how engineering teams handle secrets. Doppelgänger is a fashion and accessories online store for men and women.
- Jan 2024Conventional Debt$575.8K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.